Literature DB >> 8409314

Serum IgA antiendomysium antibody titers as a marker of intestinal involvement and diet compliance in adult celiac sprue.

C Sategna-Guidetti1, R Pulitanó, S Grosso, G Ferfoglia.   

Abstract

IgA-class antiendomysium antibodies (IgA-EmAs) are a very sensitive and specific serological marker of celiac sprue. Using an indirect immunofluorescent method, we evaluated the kinetics of the antibody titers both during a gluten-free diet and after gluten was added, comparing them with the intestinal histological pattern. The IgA-EmA titers were evaluated on sera from 91 untreated adults with biopsy-proven celiac sprue and, when positive, were reappraised after different durations of gluten-free diet. Antibody titers were also retested in eight adolescents who had voluntarily discontinued the diet while they were on a free diet. The IgA-EmAs were detectable in 85 of 91 (93.40%) patients but in none of the 438 controls (100% specificity). The antibody titers ranged from 1:5 to 1:2,000 or more and the intestinal histopathological pattern paralleled the antibody titers. After gluten withdrawal, IgA-EmA titers declined to zero in all patients complying with their diet. Modifications in gut histopathologic condition paralleled IgA-EmA kinetics, although seroconversion to negativity preceded mucosal recovery. After a gluten rechallenge, deterioration in gut histopathologic condition followed EmA reversion to positivity. Three negative IgA-EmA tests did not reflect a worsening in gut histopathologic condition after a gluten-containing diet, thus making the diagnosis of celiac sprue uncertain.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8409314     DOI: 10.1097/00004836-199309000-00007

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  13 in total

Review 1.  Endomysial antibody in the diagnosis and management of coeliac disease.

Authors:  M W James; B B Scott
Journal:  Postgrad Med J       Date:  2000-08       Impact factor: 2.401

Review 2.  Refractory sprue.

Authors:  Andrea N Culliford; Peter H R Green
Journal:  Curr Gastroenterol Rep       Date:  2003-10

3.  Seronegative celiac disease: increased prevalence with lesser degrees of villous atrophy.

Authors:  Julian A Abrams; Beverly Diamond; Heidrun Rotterdam; Peter H R Green
Journal:  Dig Dis Sci       Date:  2004-04       Impact factor: 3.199

4.  Celiac disease: management of persistent symptoms in patients on a gluten-free diet.

Authors:  David H Dewar; Suzanne C Donnelly; Simon D McLaughlin; Matthew W Johnson; H Julia Ellis; Paul J Ciclitira
Journal:  World J Gastroenterol       Date:  2012-03-28       Impact factor: 5.742

Review 5.  Tests for Serum Transglutaminase and Endomysial Antibodies Do Not Detect Most Patients With Celiac Disease and Persistent Villous Atrophy on Gluten-free Diets: a Meta-analysis.

Authors:  Jocelyn A Silvester; Satya Kurada; Andrea Szwajcer; Ciarán P Kelly; Daniel A Leffler; Donald R Duerksen
Journal:  Gastroenterology       Date:  2017-05-22       Impact factor: 22.682

6.  IgA antibodies against endomysium and transglutaminase: a comparison of methods.

Authors:  T D Jaskowski; C Schroder; T B Martins; C M Litwin; H R Hill
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

7.  Celiac disease and insulin-dependent diabetes mellitus. Screening in an adult population.

Authors:  C Sategna-Guidetti; S Grosso; R Pulitanó; E Benaduce; F Dani; Q Carta
Journal:  Dig Dis Sci       Date:  1994-08       Impact factor: 3.199

8.  Serum mannan-binding lectin levels in patients with celiac disease: an analysis of clinical and autoimmune features.

Authors:  Elisandra Grangeiro de Carvalho; Shirley Ramos da Rosa Utiyama; Lorete Maria da Silva Kotze; Iara Taborda de Messias Reason
Journal:  Dig Dis Sci       Date:  2007-03-28       Impact factor: 3.199

9.  Sero-negative celiac disease with dermatitis herpetiformes: a case report.

Authors:  Mehreen Adhi; Asma Farooq; Syed Ali Hamid; Rabia Hasan; Salman Mamji; Akhtar Ali Baloch
Journal:  Cases J       Date:  2009-05-18

10.  Duodenal biopsy may be avoided when high transglutaminase antibody titers are present.

Authors:  Santiago Vivas; Jose G Ruiz de Morales; Sabino Riestra; Laura Arias; Dolores Fuentes; Noemi Alvarez; Sara Calleja; Mercedes Hernando; Blanca Herrero; Javier Casqueiro; Luis Rodrigo
Journal:  World J Gastroenterol       Date:  2009-10-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.